CAPLIN POINT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of CAPLIN POINT LABORATORIES have increased by 14.37% YoY .
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 17.26 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
CAPLIN POINT LABORATORIES Last 5 Annual Financial Results
[BOM: 524742|NSE : CAPLIPOINT]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,937 Cr | ₹1,694 Cr | ₹1,467 Cr | ₹1,269 Cr | ₹1,061 Cr |
| Expenses | ₹1,291 Cr | ₹1,143 Cr | ₹1,026 Cr | ₹875 Cr | ₹737 Cr |
| Operating Profit (Excl OI) | ₹647 Cr | ₹551 Cr | ₹441 Cr | ₹395 Cr | ₹324 Cr |
| Other Income | ₹96 Cr | ₹67 Cr | ₹57 Cr | ₹39 Cr | ₹28 Cr |
| Interest | ₹0.61 Cr | ₹0.78 Cr | ₹0.78 Cr | ₹0.70 Cr | ₹1.59 Cr |
| Depreciation | ₹66 Cr | ₹53 Cr | ₹45 Cr | ₹47 Cr | ₹37 Cr |
| Profit Before Tax | ₹677 Cr | ₹564 Cr | ₹451 Cr | ₹386 Cr | ₹314 Cr |
| Profit After Tax | ₹541 Cr | ₹461 Cr | ₹377 Cr | ₹308 Cr | ₹251 Cr |
| Consolidated Net Profit | ₹536 Cr | ₹457 Cr | ₹376 Cr | ₹300 Cr | ₹242 Cr |
| Earnings Per Share (Rs) | ₹70.57 | ₹60.18 | ₹49.57 | ₹39.56 | ₹32.03 |
| PAT Margin (%) | 27.93 | 27.24 | 25.70 | 24.30 | 23.69 |
| ROE(%) | 21.72 | 22.97 | 23.68 | 24.77 | 25.65 |
| ROCE(%) | 26.22 | 26.92 | 26.85 | 28.77 | 28.82 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Key Financials |
||
| Market Cap | : | ₹ 14,060.4 Cr |
| Revenue (TTM) | : | ₹ 2,039.7 Cr |
| Net Profit(TTM) | : | ₹ 596.2 Cr |
| EPS (TTM) | : | ₹ 78.5 |
| P/E (TTM) | : | 23.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CAPLIN POINT LABORATORIES | -1.7% | -2.1% | -28.1% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.7% | -4.2% | -8.7% |
| DIVIS LABORATORIES | 0% | -1% | 4% |
| CIPLA | 1.1% | 0.2% | -1.9% |
| TORRENT PHARMACEUTICALS | 2.4% | 4.5% | 14.5% |
| DR REDDYS LABORATORIES | -1% | -2% | -9.7% |
| MANKIND PHARMA | 1% | -0.2% | -24.9% |
| ZYDUS LIFESCIENCES | 0.3% | -3% | -4.5% |
| LUPIN | 1.3% | 1.2% | -10.5% |
CAPLIN POINT LABORATORIES Revenues
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 14.37 % |
| 5 Yr CAGR | 16.24 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,937 Cr | 14.37 | |
| Mar2024 | ₹1,694 Cr | 15.50 | |
| Mar2023 | ₹1,467 Cr | 15.54 | |
| Mar2022 | ₹1,269 Cr | 19.61 | |
| Mar2021 | ₹1,061 Cr | - | |
CAPLIN POINT LABORATORIES Operating Profit
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 17.32 % |
| 5 Yr CAGR | 18.85 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹647 Cr | 17.32 | |
| Mar2024 | ₹551 Cr | 25.18 | |
| Mar2023 | ₹441 Cr | 11.66 | |
| Mar2022 | ₹395 Cr | 21.67 | |
| Mar2021 | ₹324 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.58 % |
| 5 Yr CAGR | 2.25 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 33.39% | 2.58 | |
| Mar2024 | 32.55% | 8.39 | |
| Mar2023 | 30.03% | -3.38 | |
| Mar2022 | 31.08% | 1.73 | |
| Mar2021 | 30.55% | - | |
CAPLIN POINT LABORATORIES Profit After Tax
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 17.33 % |
| 5 Yr CAGR | 21.98 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹536 Cr | 17.33 | |
| Mar2024 | ₹457 Cr | 21.48 | |
| Mar2023 | ₹376 Cr | 25.49 | |
| Mar2022 | ₹300 Cr | 23.76 | |
| Mar2021 | ₹242 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 2.53 % |
| 5 Yr CAGR | 4.20 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 27.93 % | 2.53 | |
| Mar2024 | 27.24 % | 5.99 | |
| Mar2023 | 25.7 % | 5.76 | |
| Mar2022 | 24.3 % | 2.57 | |
| Mar2021 | 23.69 % | - | |
CAPLIN POINT LABORATORIES Earnings Per Share (EPS)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 17.26 % |
| 5 Yr CAGR | 21.83 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹71 | 17.26 | |
| Mar2024 | ₹60 | 21.40 | |
| Mar2023 | ₹50 | 25.30 | |
| Mar2022 | ₹40 | 23.51 | |
| Mar2021 | ₹32 | - | |
CAPLIN POINT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | -2.60 % |
| 5 Yr CAGR | -2.34 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 26.22% | -2.60 | |
| Mar2024 | 26.92% | 0.26 | |
| Mar2023 | 26.85% | -6.67 | |
| Mar2022 | 28.77% | -0.17 | |
| Mar2021 | 28.82% | - | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹1,850.1 |
| Current MarketCap | : | ₹ 14,060.4 Cr |
| Updated EOD on | : | Jan 02,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | -1.7% |
-2.1% |
-28.1% |
| SENSEX | 0.9% |
0.7% |
9.6% |
CAPLIN POINT LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 400 MIDSMALLCAP INDEX | 1.5% | 0.7% | 1.2% |
| BSE 500 | 1.4% | 1.2% | 7.5% |
| BSE SMALLCAP | 1.2% | 0.2% | -5.2% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 EQUAL WEIGHT | 1.6% | 1.2% | 2% |
| NIFTY MIDSMALLCAP 400 | 1.5% | 0.9% | 2.7% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | 1.4% | 1% | 4.1% |
| NIFTY TOTAL MARKET | 1.4% | 1.1% | 7.2% |
| NIFTY500 MULTICAP 50:25:25 | 1.4% | 1.1% | 5.6% |
You may also like the below Video Courses
FAQ about CAPLIN POINT LABORATORIES Financials
How the annual revenues of CAPLIN POINT LABORATORIES have changed ?
The Revenues of CAPLIN POINT LABORATORIES have increased by 14.37% YoY .
How the Earnings per Share (EPS) of CAPLIN POINT LABORATORIES have changed?
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 17.26 % YoY .
Check out Intrinsic Value of Peers of CAPLIN POINT LABORATORIES
Compare Stock Analytics of Peers of CAPLIN POINT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
